Scott Juda - 10 Nov 2023 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Director
Signature
/s/ Scott Juda
Issuer symbol
INMB
Transactions as of
10 Nov 2023
Net transactions value
+$48,650
Form type
4
Filing time
13 Nov 2023, 11:31:53 UTC
Previous filing
21 Feb 2023
Next filing
23 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Purchase $48,650 +7,000 +23% $6.95 37,000 10 Nov 2023 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person's shares are held by Fossick Capital LP ("Fossick"), a limited partnership. The Reporting Person holds all voting and dispositive control over the Issuer's shares of common stock held by Fossick.